APA (7th ed.) Citation

Tsoi, H., Tsang, W., Man, E. P. S., Leung, M., You, C., Chan, S., . . . Khoo, U. (2022). Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer. International journal of molecular sciences, 23(20), 12290. https://doi.org/10.3390/ijms232012290

Chicago Style (17th ed.) Citation

Tsoi, Ho, Wai-Chung Tsang, Ellen P. S. Man, Man-Hong Leung, Chan-Ping You, Sum-Yin Chan, Wing-Lok Chan, and Ui-Soon Khoo. "Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer." International Journal of Molecular Sciences 23, no. 20 (2022): 12290. https://doi.org/10.3390/ijms232012290.

MLA (9th ed.) Citation

Tsoi, Ho, et al. "Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer." International Journal of Molecular Sciences, vol. 23, no. 20, 2022, p. 12290, https://doi.org/10.3390/ijms232012290.